Saxenda (liraglutide 3.0 mg) is administered once daily, not weekly—a crucial distinction that often causes confusion amongst patients considering or using this weight management medication. Unlike some other GLP-1 receptor agonists that require only weekly injections, Saxenda must be injected subcutaneously every day to maintain therapeutic drug levels. This daily dosing requirement stems from liraglutide's relatively short half-life of approximately 13 hours. Understanding the correct injection frequency, timing, and what to do if you miss a dose is essential for safe, effective treatment. This article clarifies Saxenda's dosing schedule, addresses common misconceptions, and provides practical guidance aligned with UK prescribing information and NICE recommendations.

Saxenda Dosing Schedule: Daily, Not Weekly

Saxenda (liraglutide 3.0 mg) is administered once daily, not weekly. This is a crucial distinction that often causes confusion, particularly because other GLP-1 receptor agonists used for weight management are given weekly. Saxenda must be injected subcutaneously every day, ideally at the same time each day, to maintain therapeutic drug exposure.

The daily dosing requirement stems from Saxenda's pharmacokinetic profile. Liraglutide has a half-life of approximately 13 hours, meaning the drug concentration in your bloodstream reduces by half roughly every 13 hours. This relatively short half-life necessitates daily administration to maintain steady therapeutic levels. In contrast, medications like Wegovy (semaglutide) have much longer half-lives, allowing for once-weekly dosing.

The standard Saxenda regimen follows a gradual dose escalation protocol as specified in the UK product information. Treatment begins at 0.6 mg daily for the first week, then increases weekly by 0.6 mg increments until reaching the maintenance dose of 3.0 mg daily by week five. This titration schedule helps minimise gastrointestinal side effects such as nausea and vomiting, which are common when starting GLP-1 receptor agonists.

Patients should understand that missing multiple days or attempting to use Saxenda on a weekly schedule significantly compromises treatment efficacy. The medication works by continuously activating GLP-1 receptors to suppress appetite, slow gastric emptying, and improve glycaemic control. Interrupting this daily regimen means losing these therapeutic effects.

Correct Saxenda Injection Frequency and Timing

Saxenda should be injected once every 24 hours, at approximately the same time each day. Consistency in timing helps establish a routine, improves adherence, and maintains stable drug concentrations. However, the specific time of day is flexible—you may inject Saxenda in the morning, afternoon, or evening, depending on what best suits your lifestyle and minimises side effects.

Many patients find that injecting Saxenda in the evening can help manage nausea, as any gastrointestinal discomfort may occur during sleep. Others prefer morning administration to align with their daily routine. The key is selecting a time you can maintain consistently. If you need to change your injection time, you may do so, provided at least 12 hours have passed since your last dose.

The injection is administered subcutaneously (under the skin) into the abdomen, thigh, or upper arm. Rotate injection sites within the same body region to reduce the risk of injection site reactions. The abdomen is often preferred as it typically provides consistent absorption, though all three sites are equally effective when used correctly.

Saxenda can be taken with or without food, as food intake does not significantly affect liraglutide absorption. This flexibility allows you to integrate the injection into your daily schedule without meal-time restrictions. The pre-filled pen device makes self-administration straightforward, delivering precise doses without the need for manual measurement.

Regarding storage, unopened Saxenda pens should be refrigerated (2-8°C) and not frozen. After first use, the pen can be stored at room temperature (below 30°C) or in a refrigerator for up to 30 days.

If you're uncertain about injection technique or timing, consult your GP, practice nurse, or pharmacist for practical demonstration and personalised advice. Proper injection technique ensures optimal drug delivery and treatment outcomes.

Common Misconceptions About Saxenda Dosing

One of the most prevalent misconceptions is confusing Saxenda with weekly GLP-1 medications. Patients sometimes mistakenly believe they can use Saxenda once or twice weekly, similar to semaglutide formulations like Wegovy. This confusion is understandable given that these medications belong to the same drug class and share similar mechanisms of action, but their dosing schedules differ fundamentally due to distinct pharmacokinetic properties. It's important to note that in the UK, Wegovy is licensed for weight management, while Ozempic is only licensed for type 2 diabetes treatment, not weight management.

Another common misunderstanding involves the dose escalation phase. Some patients believe the weekly increases during the first five weeks mean they only inject once per week during this period. In reality, you inject daily throughout escalation—what changes weekly is the dose amount, not the frequency. Each week, you increase the daily dose by 0.6 mg until reaching the 3.0 mg maintenance dose.

Some individuals question whether they can 'make up' for missed doses by injecting twice in one day or increasing the dose. This practice is strongly discouraged. Taking more than the prescribed daily dose increases the risk of adverse effects, particularly severe nausea and vomiting. For patients also taking insulin or sulfonylureas, there's an increased risk of hypoglycaemia, and these medications may need dose adjustment. There is no evidence that compensatory dosing improves weight loss outcomes.

Patients occasionally believe that once they've achieved their target weight, they can reduce injection frequency rather than stopping treatment entirely. However, Saxenda is not designed for intermittent use. NICE guidance (TA664) recommends discontinuing Saxenda if patients haven't lost at least 5% of initial body weight after 12 weeks at the maintenance dose, as continued treatment is unlikely to provide meaningful benefit.

If you have questions about your Saxenda regimen, always consult your prescribing clinician rather than adjusting the schedule independently. Proper adherence to the daily dosing protocol is essential for safe, effective treatment.

What Happens If You Miss a Saxenda Dose

If you miss a Saxenda dose, the recommended action depends on how much time has elapsed. According to UK product information, if fewer than 12 hours have passed since your usual injection time, administer the missed dose as soon as you remember. Then resume your regular schedule the following day. This approach maintains relatively stable drug levels without significant therapeutic interruption.

However, if more than 12 hours have passed since your scheduled dose, skip the missed injection entirely and wait until your next scheduled dose the following day. Do not inject a double dose to compensate for the missed injection, as this increases the risk of adverse effects, particularly gastrointestinal symptoms like nausea, vomiting, and diarrhoea. Taking excessive liraglutide does not accelerate weight loss and may cause unnecessary discomfort.

Missing occasional doses is unlikely to cause serious harm, but it may temporarily reduce appetite suppression and metabolic benefits. You might notice increased hunger or reduced satiety on days when therapeutic levels drop. Frequent missed doses compromise treatment efficacy and may result in inadequate weight loss. If you're struggling with adherence, discuss strategies with your healthcare provider, such as setting phone reminders or linking injections to established daily routines.

If you've missed multiple consecutive doses (typically more than three days), contact your GP or prescribing clinician before resuming treatment. You should restart at 0.6 mg and re-escalate gradually to minimise gastrointestinal side effects. Abruptly resuming at 3.0 mg after an extended break may cause significant nausea.

Seek urgent medical attention if you experience severe, persistent upper abdominal pain (with or without vomiting) which could indicate pancreatitis, signs of gallbladder disease, severe dehydration, or allergic reactions while using Saxenda. Report any suspected side effects via the MHRA Yellow Card Scheme.

Patients should also be aware that if Saxenda has been stored incorrectly during the missed period (for example, left out of the refrigerator beyond the recommended storage period or frozen), the medication may have degraded and should not be used. Always check storage requirements and expiry dates, and consult your pharmacist if you have concerns about medication integrity.

Frequently Asked Questions